AzTrials
AzTrials

SCHIZOPHRENIA 1 (Disorder)MBY-SCZNCT07497516

Mindfulness-Based Yoga in Schizophrenia

A study testing Mindfulness-Based Yoga in people with SCHIZOPHRENIA 1 (Disorder), run by Tarsus University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial aimed to evaluate the effect of mindfulness-based yoga on psychological well-being and happiness in individuals diagnosed with schizophrenia. Participants were recruited from community mental health centers and randomly assigned to either an intervention group or a control group. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
SCHIZOPHRENIA 1 (Disorder)
What is being tested?
Mindfulness-Based Yoga
Could I receive a placebo?
No, everyone receives an active treatment
How many people
91 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Feb 2024to 1 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosed with schizophrenia according to DSM-5 criteria
  • Aged between 18 and 65 years
  • Willing to participate in the study
  • Able to provide informed consent

Who cannot join

  • Being in an acute exacerbation phase of schizophrenia
  • Participation in mindfulness or yoga training within the last 6 months
  • Presence of comorbid neurological or cognitive disorders (e.g., dementia, delirium, intellectual disability, or history of head trauma)
  • Current substance use

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Tarsus University

    Mersin, Tarsus, 33400

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Mindfulness-Based Yoga on Psychological Well-Being and Happiness in Individuals With Schizophrenia: A Randomized Controlled Trial

This randomized controlled trial aimed to evaluate the effect of mindfulness-based yoga on psychological well-being and happiness in individuals diagnosed with schizophrenia. Participants were recruited from community mental health centers and randomly assigned to either an intervention group or a control group.

The intervention group participated in a structured mindfulness-based yoga program consisting of 12 sessions over six weeks, including mindfulness practices, breathing exercises, meditation, and yoga postures. The control group received routine care without additional intervention.

Primary outcomes included psychological well-being and happiness, measured using validated scales at baseline and post-intervention. The findings of the study are expected to contribute to the development of psychosocial interventions that support mental health and well-being in individuals with schizophrenia.

Being tested
Mindfulness-Based Yoga
Keywords
Schizophrenia Mindfulness Yoga Mindfulness-Based Yoga Psychological Well-Being Happiness Randomized Controlled Trial

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness-Based YogaBehavioural

    A structured mindfulness-based yoga program consisting of 12 sessions delivered over 6 weeks. The program includes mindfulness practices, breathing exercises, meditation, and yoga postures conducted in group sessions.

Study groups in NCT07497516
Study groupRoleWhat they receive
Mindfulness-Based YogaExperimentalParticipants receive a structured mindfulness-based yoga program consisting of 12 sessions over 6 weeks.
Receives: Behavioral: Mindfulness-Based Yoga
Routine CareNo interventionParticipants receive routine care without additional intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Psychological Well-Being

    Psychological well-being will be assessed using the Psychological Well-Being Scale (PWB), a validated self-report instrument consisting of 8 items rated on a 7-point Likert scale. Higher scores indicate greater psychological well-being.

    Measured: Baseline and 6 weeks (post-intervention)

  2. Happiness

    Happiness will be assessed using the Oxford Happiness Questionnaire Short Form (OHQ-SF), a validated self-report scale. Higher scores indicate greater levels of happiness.

    Measured: Baseline and 6 weeks (post-intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Mar 2026
  2. Study start1 Feb 2024
  3. Primary completion1 Aug 2024
  4. Study completion1 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
91 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07497516
Sponsor's protocol ID
MBY-SCZ-RCT-2024
Acronym
MBY-SCZ
Status last verified
Mar 2026
First submitted
23 Mar 2026
Last updated
27 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness-Based Yoga in people with SCHIZOPHRENIA 1 (Disorder), run by Tarsus University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Psychological Well-Being (time frame: Baseline and 6 weeks (post-intervention)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in